Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1245 W Fairbanks Avenue suite 305
Winter Park, FL 32789Phone+1 407-293-1122Fax+1 407-253-2170
Summary
- Dr. Ronald Davis is a Child Neurologist in Orlando, FL and is affiliated with multiple hospitals in the area, including Orlando Regional Medical Center, Health Central Hospital, and Lawnwood Regional Medical Center & Heart Institute. He received his medical degree from Brody School of Medicine at East Carolina University and has been in practice 27 years. He is experienced in child neurology, epilepsy, neurodevelopmental disabilities, pediatric epilepsy, and pain management.
Education & Training
- Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Child Neurology, 1992 - 1995
- ECU Health Medical Center/East Carolina UniversityInternship, Pediatrics, 1990 - 1992
- Brody School of Medicine at East Carolina UniversityClass of 1990
Certifications & Licensure
- FL State Medical License 2000 - 2026
- MA State Medical License 1993 - 2025
- NC State Medical License 1991 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
- National Board of Physicians and Surgeons Neurology with Special Qualification in Child Neurology
- National Board of Physicians and Surgeons Pediatrics
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Start of enrollment: 2014 Feb 28
Publications & Presentations
PubMed
- 24 citationsAdjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy:J. Ben Renfroe, Mark Mintz, Ronald W. Davis, Jose A. Ferreira, Sharon Dispoto
Journal of Child Neurology. 2019-02-10 - 38 citationsEfficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.Kelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, Joseph E Sullivan, Katherine C Nickels
JAMA Neurology. 2022-06-01 - 14 citationsFenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extensi...Kelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C Nickels
Epilepsia. 2023-01-01
Press Mentions
- How to Bring the Public into the Scientific ProcessMarch 14th, 2022
- 2017 Patient Recommendations for TOP Neurologists…Epileptologists… Neurosurgeons…and Pediatric Doctors | January 14, 2017January 14th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: